Argenica Therapeutics (ASX:AGN) - Webinar Presentation

17/04/2023 09:50:00

This video is not supported on your device. Click here for the original version.

Dr Liz Dallimore - CEO & Managing Director - Argenica Therapeutics Limited (ASX:AGN) is developing novel neuroprotective therapeutics to reduce brain damage after stroke.